AKBA Akebia Therapeutics
- 1.1800
- -0.0500-4.07%
- 1.1601
- -0.0199-1.69%
Akebia Therapeutics News
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hadas Nicole R.
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dahan Michel
Akebia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Akebia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burke Steven Keith
Akebia Therapeutics | 10-Q: Quarterly report
Akebia Therapeutics | 8-K: Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Akebia Therapeutics | DEF 14A: Definitive information statements
Akebia Therapeutics | DEFA14A: Others
Akebia Therapeutics | ARS: Annual Report to Security Holders
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 8-K: Current report
Akebia Therapeutics | 10-K: Annual report
Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dahan Michel
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hadas Nicole R.
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Butler John P.
Akebia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burke Steven Keith
Analysis
Price Target
No Data
